| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.34B | 1.91B | 1.57B | 1.40B | 1.12B | 848.78M |
| Gross Profit | 1.92B | 1.70B | 1.43B | 989.43M | 810.40M | 616.76M |
| EBITDA | 644.63M | 697.39M | 510.98M | 105.70M | 49.51M | 77.61M |
| Net Income | 272.41M | 207.03M | 160.21M | -113.53M | -9.11M | 19.69M |
Balance Sheet | ||||||
| Total Assets | 6.10B | 4.06B | 2.95B | 2.33B | 2.35B | 2.02B |
| Cash, Cash Equivalents and Short-Term Investments | 4.21B | 2.12B | 1.53B | 1.05B | 870.02M | 1.11B |
| Total Debt | 1.18B | 1.22B | 1.22B | 1.07B | 949.03M | 951.21M |
| Total Liabilities | 2.09B | 2.06B | 1.56B | 1.34B | 1.31B | 1.28B |
| Stockholders Equity | 4.01B | 2.00B | 1.39B | 986.53M | 1.04B | 745.95M |
Cash Flow | ||||||
| Free Cash Flow | 970.56M | 799.66M | 585.17M | 102.22M | -4.43M | 57.90M |
| Operating Cash Flow | 983.11M | 812.82M | 591.76M | 381.52M | 240.83M | 221.42M |
| Investing Cash Flow | -412.54M | -403.75M | -242.01M | -304.90M | -430.04M | -197.97M |
| Financing Cash Flow | 2.08B | -177.17M | -93.26M | -303.10M | -61.52M | 544.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$914.53M | 23.85 | 65.33% | 10.16% | 25.67% | 744.90% | |
70 Outperform | $13.59B | 51.27 | 8.14% | ― | 19.01% | 19.06% | |
69 Neutral | AU$15.13B | 62.57 | 12.61% | 0.32% | 15.51% | 17.38% | |
65 Neutral | AU$1.23B | 33.34 | 35.71% | 1.27% | 5.11% | 12.91% | |
63 Neutral | AU$8.17B | 61.88 | 32.67% | 0.83% | 18.16% | 16.25% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | €1.34B | 17.50 | 26.73% | 2.47% | -4.10% | 341.80% |
Xero Limited has outlined its proposed key dates for the financial year ending 31 March 2027, giving investors and stakeholders a clear timetable for governance and reporting events. The schedule includes a 9 July 2026 deadline for director nominations to the Xero board and its annual meeting set for 27 August 2026.
The company plans to release its FY27 half-year results for the period to 30 September 2026 on 12 November 2026, followed by its full-year FY27 results on 20 May 2027. By setting out this timetable in advance, Xero provides greater visibility into its corporate calendar, supporting planning for shareholders, analysts and other market participants.
The most recent analyst rating on (AU:XRO) stock is a Hold with a A$79.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has notified the market that it has issued 65,266 unquoted restricted stock units under its employee incentive scheme, with the securities coded XROAK and dated 28 January 2026. The new equity awards, which are subject to transfer restrictions and will not be quoted on the ASX until those restrictions lapse, underscore Xero’s continued use of equity-based remuneration to attract and retain staff, aligning employees’ interests with shareholders and potentially leading to future dilution once the securities vest and become tradable.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$210.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has released an investor briefing presentation dated 3 February 2026, led by Chief Executive Officer Sukhinder Singh Cassidy and senior executives including the Chief Financial Officer, US CEO and Chief Product and Technology Officer, underscoring the company’s ongoing engagement with the investment community. The presentation outlines that the material is for general information only, is not an offer or recommendation to invest, may include non-GAAP financial measures, and contains forward-looking and past-performance statements that are subject to uncertainties, signalling a standard but important reminder to investors to interpret the company’s reported performance and outlook with caution and in conjunction with its formal financial reports and market releases.
The most recent analyst rating on (AU:XRO) stock is a Hold with a A$103.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has applied to the ASX for quotation of a small tranche of new fully paid ordinary shares, totaling 51,876 securities issued on various dates between December 2025 and January 2026. The additional shares, arising from the exercise or conversion of existing options or other convertible securities, represent a minor increase in Xero’s listed capital base and reflect routine equity issuance activity rather than a major change in strategy or capital structure.
The most recent analyst rating on (AU:XRO) stock is a Hold with a A$105.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has notified the market of the cessation of several equity-based instruments, including a total of 54,279 restricted stock units and 994 options, which have lapsed because their vesting or performance conditions were not met or became incapable of being satisfied between late November 2025 and mid-January 2026. The lapses reduce the pool of potential future shares under these incentive schemes and slightly tighten the company’s prospective issued capital base, signaling routine adjustments to its employee and executive equity plans without indicating any immediate operational or strategic shift.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$155.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has announced that 1,255,936 securities issued on 21 November 2025 as part of its acquisition of Melio have been released from voluntary escrow and are now freely tradable, in line with the terms of the previously disclosed transaction. The company noted that this regulatory notice was lodged later than required under ASX Listing Rules due to an administrative oversight, highlighting a compliance lapse even as the post-acquisition integration phase sees these shares move into the market, potentially increasing Xero’s free float and liquidity for investors.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has issued 49,032 fully paid ordinary shares to complete the previously announced acquisition of Melio Ltd, marking the share-based component of the transaction’s consideration. The company confirmed that the new shares were issued without a prospectus under the relevant Australian Corporations Act provisions, that it remains compliant with its financial reporting and continuous disclosure obligations, and that there is no excluded information that would affect the market, signalling a routine, regulatorily compliant equity issuance to support its expansion in small-business payments.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has applied for quotation on the ASX of 49,032 new ordinary fully paid shares, to be issued on 31 December 2025. The additional securities, which stem from previously disclosed transactions, will modestly increase the company’s free float and share capital, potentially enhancing liquidity for investors while signalling ongoing use of equity-related arrangements within its capital management strategy.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has announced a virtual briefing session in collaboration with Melio, scheduled for February 3, 2026. The session will feature product demonstrations and educational segments aimed at investors and analysts, followed by a live Q&A. This initiative underscores Xero’s commitment to engaging with stakeholders and showcasing its product capabilities, potentially enhancing its market positioning and stakeholder relations.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$200.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has announced the quotation of additional securities on the Australian Securities Exchange (ASX), with a total of 97,478 ordinary fully paid shares to be quoted. This move is part of the company’s ongoing efforts to enhance its financial flexibility and support its growth strategy, potentially impacting its market positioning by increasing its capital base.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$200.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.
Xero Limited has announced the issuance of 898,723 restricted stock units as part of a previously disclosed transaction. This move, which involves unquoted securities not intended for ASX listing, reflects the company’s ongoing strategy to manage its equity and incentivize stakeholders, potentially impacting its financial structure and market positioning.
The most recent analyst rating on (AU:XRO) stock is a Buy with a A$194.00 price target. To see the full list of analyst forecasts on Xero Limited stock, see the AU:XRO Stock Forecast page.